3.3. DEN Treatment Induces Activation of MAPK, AKT, and YAP Pathways in Pre-Malignant Liver Tissues of WT, HE, and HO Mice, with AKT Activation Being Affected by (Partial) Loss of Ppp2r5d. This evidence concerns the gene AKT1 and hereditary elliptocytosis.